Immunoprotective activity of ribosomes from Haemophilus influenzae
- PMID: 300360
- PMCID: PMC421389
- DOI: 10.1128/iai.15.2.453-460.1977
Immunoprotective activity of ribosomes from Haemophilus influenzae
Abstract
Immunization with ribosomal preparations from Haemophilus influenzae type b elicited protective immunity in mice. Ribosomes from disrupted cells where isolated by differential centrifugation using sodium dodecyl sulfate. The washed ribosomes contained 25% protein and 75% ribonucleic acid and sedimented as a single peak on sucrose density gradient analysis with a sedimentation coefficient of 67S, using Escherichia coli ribosomes as a 70S marker. Immunodiffusion tests with antipolyribose phosphate serum showed that the ribosomes were free from capsular material. Mice immunized subcutaneously with ribosomes, with or without adjuvant, were challenged intraperitoneally with 100 to 1,000 mean lethal doses of H. influenzae type b suspended in gastric mucin. Significant protection was induced by ribosomes and was compared to that obtained after sublethal infection with live cells. The protection was greatly enhanced after incorporation of ribosomes into adjuvants. Maximum protection (90 to 95%) was observed at 1 to 2 weeks after immunization. Ribosomes from a nonencapsulated strain of H. influenzae were as immunogenic as those from the encapsulated strain, demonstrating that the capsular material is not responsible for immunogenicity of Haemophilus ribosomes.
Similar articles
-
Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.Infect Immun. 1978 Jan;19(1):58-65. doi: 10.1128/iai.19.1.58-65.1978. Infect Immun. 1978. PMID: 304844 Free PMC article.
-
Enhancement of immunogenic activity of ribosomal preparations from Haemophilus influenzae by various adjuvants.Vaccine. 1985 Jun;3(2):103-8. doi: 10.1016/0264-410x(85)90057-x. Vaccine. 1985. PMID: 3875945
-
Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum.Infect Immun. 1974 Nov;10(5):1091-7. doi: 10.1128/iai.10.5.1091-1097.1974. Infect Immun. 1974. PMID: 16558095 Free PMC article.
-
Haemophilus influenzae: immunology and immunoprotection.CRC Crit Rev Microbiol. 1978 Sep;6(1):1-32. doi: 10.3109/10408417809090618. CRC Crit Rev Microbiol. 1978. PMID: 359242 Review. No abstract available.
-
Epidemiology and prevention of respiratory tract infections due to nonencapsulated Haemophilus influenzae.J Infect Dis. 1992 Jun;165 Suppl 1:S177-80. doi: 10.1093/infdis/165-supplement_1-s177. J Infect Dis. 1992. PMID: 1588158 Review.
Cited by
-
Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.Infect Immun. 1977 Aug;17(2):471-3. doi: 10.1128/iai.17.2.471-473.1977. Infect Immun. 1977. PMID: 408275 Free PMC article.
-
Serological and biological activities of anti-Haemophilus influenzae ribosomal serum.Infect Immun. 1981 Mar;31(3):1125-31. doi: 10.1128/iai.31.3.1125-1131.1981. Infect Immun. 1981. PMID: 6971811 Free PMC article.
-
Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.Infect Immun. 1979 Feb;23(2):509-21. doi: 10.1128/iai.23.2.509-521.1979. Infect Immun. 1979. PMID: 106013 Free PMC article.
-
Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.Infect Immun. 1978 Jul;21(1):76-86. doi: 10.1128/iai.21.1.76-86.1978. Infect Immun. 1978. PMID: 101464 Free PMC article.
-
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.J Clin Invest. 1982 Apr;69(4):742-9. doi: 10.1172/jci110512. J Clin Invest. 1982. PMID: 7042755 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources